Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia-Reference-Cited by-同舟云学术

Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia

Published:2011-08-23 Issue:5 Volume:87 Page:426-433
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Chow Kai Uwe,Kim Soo-Zin,von Neuhoff Nils,Schlegelberger Brigitte,Stilgenbauer Stephan,Wunderle Lydia,Cordes Hans-Joerg,Bergmann Lothar

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2011.01680.x/fullpdf

Reference24 articles.

1. Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011;Byrd;Blood,2005

2. Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia;Eichhorst;Blood,2006

3. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia;Rai;N Engl J Med,2000

4. Select high-risk genetic featurespreict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia. Justification for risk-adapted therapy;Byrd;J Clin Oncol,2006

5. Genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course;Stilgenbauer;Leukemia,2002

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases;Translational Cancer Research;2023-07

2. B-Cell Prolymphocytic Leukemia: Clinical Profile and Treatment Outcomes at a Tertiary Cancer Center in South India;Oncology Journal of India;2023

3. A new case of trisomy 5 with complex karyotype abnormalities in B-cell prolymphocytic leukemia: a case study;Egyptian Journal of Medical Human Genetics;2022-03-03

4. Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax;Leukemia Research Reports;2021

5. Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemia;Investigational New Drugs;2020-01-22